Zofia Bakuła

Zofia Bakuła

Auto-generated profile, based on publicly available information

Zofia Bakuła

Department of Medical Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TJTomasz Jagielski
Tomasz Jagielski
HIHelena Ignatowska
Helena Ignatowska
ZBZofia Bakuła
Zofia Bakuła
LDLukasz Dziewit
Lukasz Dziewit
ANAgnieszka Napiórkowska
Agnieszka Napiórkowska
JBJacek Bielecki
Jacek Bielecki
Currently, mutations in three genes, namely rrs, rpsL, and gidB, encoding 16S rRNA, ribosomal protein S12, and 16S rRNA-specific methyltransferase, respectively, are considered to be involved in conferring resistance to streptomycin (STR) in Mycobacterium tuberculosis. The aim of this study was to investigate the spectrum and frequency of these mutations in M. tuberculosis clinical isolates, both resistant and susceptible to STR. Sixty-four M. tuberculosis isolates recovered from as many TB patients from Poland in 2004 were included in the study. Within the sample were 50 multidrug-resistant (32 STR-resistant and 18 STR-susceptible) and 14 pan-susceptible isolates. Preliminary testing for STR resistance was performed with the 1% proportion method. The MICs of STR were determined by the Etest method. Mutation profiling was carried out by amplifying and sequencing the entire rrs, rpsL, and gidB genes. Non-synonymous mutations in either rrs or rpsL gene were detected in 23 (71.9%) of the STR-resistant and none of the STR-susceptible isolates. Mutations in the gidB gene were distributed among 12 (37.5%) STR-resistant and 13 (40.6%) STR-susceptible isolates. Four (12.5%) STR-resistant isolates were wild-type at all three loci examined. None of the rrs, rpsL or gidB mutations could be linked to low, intermediate or high level of STR resistance. In accordance with previous findings, the gidB 47T→G (L16R) mutation was associated with the Latin American-Mediterranean genotype family, whereas 276A→C (E92D) and 615A→G (A205A) mutations of the gidB gene were associated with the Beijing lineage. The study underlines the usefulness of rrs and rpsL mutations as molecular markers for STR resistance yet not indicative of its level. The gidB polymorphisms can serve as phylogenetic markers.

22 May 2014 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Closed access
PDF file
TJTomasz Jagielski
Tomasz Jagielski
ZBZofia Bakuła
Zofia Bakuła
KRKatarzyna Roeske
Katarzyna Roeske
MKMichał Kamiński
Michał Kamiński
ANAgnieszka Napiórkowska
Agnieszka Napiórkowska
JBJacek Bielecki
Jacek Bielecki
Objectives To determine the prevalence of isoniazid resistance-conferring mutations among multidrug-resistant (MDR) isolates of Mycobacterium tuberculosis from Poland. Methods Nine genetic loci, including structural genes (katG, inhA, ahpC, kasA, ndh, nat and mshA) and regulatory regions (i.e. the mabA-inhA promoter and oxyR-ahpC intergenic region) of 50 MDR M. tuberculosis isolates collected throughout Poland were PCR-amplified in their entirety and screened for mutations by direct sequencing methodology. Results Forty-six (92%) MDR M. tuberculosis isolates had mutations in the katG gene, and the katG Ser315Thr substitution predominated (72%). Eight (16%) isolates (six with a mutated katG allele) had mutations in the inhA promoter region and two such isolates also had single inhA structural gene mutations. Mutations in the oxyR-ahpC locus were found in five (10%) isolates, of which all but one had at least one additional mutation in katG. Mutations in the remaining genetic loci (kasA, ndh, nat and mshA) were detected in 12 (24%), 4 (8%), 5 (10%) and 17 (34%) MDR isolates, respectively. All non-synonymous mutants for these genes harboured mutations in katG. One isolate had no mutations in any of the analysed loci. Conclusions This study accentuates the usefulness of katG and inhA promoter mutations as predictive markers of isoniazid resistance. Testing only for katG 315 and inhA –15 mutations would detect isoniazid resistance in 84% of the MDR M. tuberculosis sample. This percentage would increase to 96% if the sequence analysis was extended to the entire katG gene. Analysis of the remaining genetic loci did not contribute greatly to the identification of isoniazid resistance.

1 October 2018 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
TJTomasz Jagielski
Tomasz Jagielski
JGJan Gawor
Jan Gawor
ZBZofia Bakuła
Zofia Bakuła
PDPrzemyslaw Decewicz
Przemyslaw Decewicz
KMKacper Maciszewski
Kacper Maciszewski
AKAnna Karnkowska
Anna Karnkowska
Achlorophyllous unicellular microalgae of the genus Prototheca ( Trebouxiophyceae , Chlorophyta ) are the only known plants that cause infections in both humans and animals, collectively referred to as protothecosis. Human protothecosis, most commonly manifested as cutaneous, articular, and disseminated disease, is primarily caused by Prototheca wickerhamii , followed by Prototheca zopfii and, sporadically, by Prototheca cutis and Prototheca miyajii .

3 October 2017 in Plant Methods
Verified
Journal Article
Open access
PDF file
TJTomasz Jagielski
Tomasz Jagielski
JGJan Gawor
Jan Gawor
ZBZofia Bakuła
Zofia Bakuła
KZKarolina Zuchniewicz
Karolina Zuchniewicz
IŻIwona Żak
Iwona Żak
RGRobert Gromadka
Robert Gromadka
The complex cell wall structure of algae often precludes efficient extraction of their genetic material. The purpose of this study was to design a next-generation sequencing-suitable DNA isolation method for unicellular, achlorophyllous, yeast-like microalgae of the genus Prototheca, the only known plant pathogens of both humans and animals. The effectiveness of the newly proposed scheme was compared with five other, previously described methods, commonly used for DNA isolation from plants and/or yeasts, available either as laboratory-developed, in-house assays, based on liquid nitrogen grinding or different enzymatic digestion, or as commercially manufactured kits. All five, previously described, isolation assays yielded DNA concentrations lower than those obtained with the new method, averaging 16.15 ± 25.39 vs 74.2 ± 0.56 ng/µL, respectively. The new method was also superior in terms of DNA purity, as measured by A260/A280 (−0.41 ± 4.26 vs 2.02 ± 0.03), and A260/A230 (1.20 ± 1.12 vs 1.97 ± 0.07) ratios. Only the liquid nitrogen-based method yielded DNA of comparable quantity (60.96 ± 0.16 ng/µL) and quality (A260/A280 = 2.08 ± 0.02; A260/A230 = 2.23 ± 0.26). Still, the new method showed higher integrity, which was best illustrated upon electrophoretic analysis. Genomic DNA of Prototheca wickerhamii POL-1 strain isolated with the protocol herein proposed was successfully sequenced on the Illumina MiSeq platform. A new method for DNA isolation from Prototheca algae is described. The method, whose protocol involves glass beads pulverization and cesium chloride (CsCl) density gradient centrifugation, was demonstrated superior over the other common assays in terms of DNA quantity and quality. The method is also the first to offer the possibility of preparation of DNA template suitable for whole genome sequencing of Prototheca spp.

1 October 2018 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
TJTomasz Jagielski
Tomasz Jagielski
ZBZofia Bakuła
Zofia Bakuła
ABAnna Brzostek
Anna Brzostek
AMAlina Minias
Alina Minias
RSRadosław Stachowiak
Radosław Stachowiak
JDJaroslaw Dziadek
Jaroslaw Dziadek
Resistance ofMycobacterium tuberculosisto rifampin (RMP), mediated by mutations in therpoBgene coding for the beta-subunit of RNA polymerase, poses a serious threat to the efficacy of clinical management and, thus, control programs for tuberculosis (TB). The contribution of many individualrpoBmutations to the development and level of RMP resistance remains elusive.

1 April 2018 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
ZBZofia Bakuła
Zofia Bakuła
MMMagdalena Modrzejewska
Magdalena Modrzejewska
LPLian Pennings
Lian Pennings
MPMalgorzata Proboszcz
Malgorzata Proboszcz
ASAleksandra Safianowska
Aleksandra Safianowska
TJTomasz Jagielski
Tomasz Jagielski
Very few studies have examined drug susceptibility of Mycobacterium kansasii , and they involve a limited number of strains. The purpose of this study was to determine drug susceptibility profiles of M. kansasii isolates representing a spectrum of species genotypes (subtypes) with two different methodologies, i.e., broth microdilution and Etest assays. To confirm drug resistance, drug target genes were sequenced. A collection of 85 M. kansasii isolates, including representatives of eight different subtypes (I to VI, I/II, and IIB) from eight countries, was used. Drug susceptibility against 13 and 8 antimycobacterial agents was tested by using broth microdilution and Etest, respectively. For drug-resistant or high-MIC isolates, eight structural genes ( rrl , katG , inhA , embB , rrs , rpsL , gyrA , and gyrB ) and one regulatory region ( embCA ) were PCR amplified and sequenced in the search for resistance-associated mutations. All isolates tested were susceptible to rifampin (RIF), amikacin (AMK), co-trimoxazole (SXT), rifabutin (RFB), moxifloxacin (MXF), and linezolid (LZD) according to the microdilution method. Resistance to ethambutol (EMB), ciprofloxacin (CIP), and clarithromycin (CLR) was found in 83 (97.7%), 17 (20%), and 1 (1.2%) isolate, respectively. The calculated concordance between the Etest and dilution method was 22.6% for AMK, 4.8% for streptomycin (STR), 3.2% for CLR, and 1.6% for RIF. For EMB, INH, and SXT, not even a single MIC value determined by one method equaled that by the second method. The only mutations disclosed were A2266C transversion at the rrl gene (CLR-resistant strain) and A128G transition at the rpsL gene (strain with STR MIC of >64 mg/liter). In conclusion, eight drugs, including RIF, CLR, AMK, SXT, RFB, MXF, LZD, and ethionamide (ETO), showed high in vitro activity against M. kansasii isolates. Discrepancies of the results between the reference microdilution method and Etest preclude the use of the latter for drug susceptibility determination in M. kansasii . Drug resistance in M. kansasii may have different genetic determinants than resistance to the same drugs in M. tuberculosis .